TheraRadar
← Back
Data updated: Mar 29, 2026

VERONA PHARMA

RespiratoryInfectious Disease
Pharma

VERONA PHARMA is a pharmaceutical company focused on Respiratory, Infectious Disease. Key products include OHTUVAYRE.

2024
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

OHTUVAYRE
ensifentrine
Respiratory
PDE3 1 indications · 2024

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

OHTUVAYRE 2024-06-26
Type 1 - New Molecular Entity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 96%
1 drugs Phase 3: 3 Phase 2: 14
Infectious Disease 4%
0 drugs Phase 2: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GSK big-pharma
Infectious Disease, Respiratory
Sanofi big-pharma
Infectious Disease, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Respiratory
APOTHECON specialty
Infectious Disease, Respiratory
PHARMACIA AND UPJOHN big-pharma
Infectious Disease, Respiratory